{"pmid":32415893,"title":"Coronavirus (COVID-19): Patient experience-Administrative services on the frontline during crisis.","text":["Coronavirus (COVID-19): Patient experience-Administrative services on the frontline during crisis.","The COVID-19 pandemic has had a dramatic impact on care delivery among health care institutions and providers in the United States. As a categorical cancer center, MD Anderson has prioritized care for our patients based on acuity of their disease. We continue to implement measures to protect patients and employees from acquiring the infection within our facilities, and to provide acute management of cancer patients with concomitant COVID-19 infections who are considered at high risk of death. The Division of Patient Experience, formerly established in October 2016, has played an integral role in the institution's pandemic response from its inception. The team actively supported programs and processes in anticipation of the pandemic's effect on our patients and employees. We will describe how the team continues to serve in the ever-dynamic environment as we approach the expected surge in COVID-19 cases among our patient population, our employees, and in our community.","Head Neck","Overton, Judy","Denton, Kathy","Frumovitz, Michael","Lewis, Carol","Christensen, Sarah","Bezerra, Jaymesson","Hernandez, Chris","Walker, Michele S","Finder, Janice P","Proske, Ashlyn A","Jain, Sanchita","Whipple, Julai","Martinez, Wendi L","Eska, Jarrod S","Sutherland, Elizabeth W","Triche, Lisa L","Garcia, Elizabeth A","Weber, Randal","32415893"],"abstract":["The COVID-19 pandemic has had a dramatic impact on care delivery among health care institutions and providers in the United States. As a categorical cancer center, MD Anderson has prioritized care for our patients based on acuity of their disease. We continue to implement measures to protect patients and employees from acquiring the infection within our facilities, and to provide acute management of cancer patients with concomitant COVID-19 infections who are considered at high risk of death. The Division of Patient Experience, formerly established in October 2016, has played an integral role in the institution's pandemic response from its inception. The team actively supported programs and processes in anticipation of the pandemic's effect on our patients and employees. We will describe how the team continues to serve in the ever-dynamic environment as we approach the expected surge in COVID-19 cases among our patient population, our employees, and in our community."],"journal":"Head Neck","authors":["Overton, Judy","Denton, Kathy","Frumovitz, Michael","Lewis, Carol","Christensen, Sarah","Bezerra, Jaymesson","Hernandez, Chris","Walker, Michele S","Finder, Janice P","Proske, Ashlyn A","Jain, Sanchita","Whipple, Julai","Martinez, Wendi L","Eska, Jarrod S","Sutherland, Elizabeth W","Triche, Lisa L","Garcia, Elizabeth A","Weber, Randal"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32415893","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1002/hed.26259","keywords":["cancer patients","coronavirus","exemptions","no visitor policy","patient experience"],"locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666991242689380353,"score":9.490897,"similar":[{"pmid":32474129,"title":"Mitigating the Impact of COVID-19 on Oncology: Clinical and Operational Lessons from a Prospective Radiation Oncology Cohort Tested for COVID-19.","text":["Mitigating the Impact of COVID-19 on Oncology: Clinical and Operational Lessons from a Prospective Radiation Oncology Cohort Tested for COVID-19.","BACKGROUND AND PURPOSE: The COVID-19 pandemic warrants operational initiatives to minimize transmission, particularly among cancer patients who are thought to be at high-risk. Within our department, a multidisciplinary tracer team prospectively monitored all patients under investigation, tracking their test status, treatment delays, clinical outcomes, employee exposures and quarantines. MATERIALS AND METHODS: Prospective cohort tested for SARS-COV-2 infection over 35 consecutive days of the early pandemic (03/19/2020-04/22/2020). RESULTS: A total of 121 Radiation Oncology patients underwent RT-PCR testing during this timeframe. Of the 7 (6%) confirmed-positive cases, 6 patients were admitted (including 4 warranting intensive care), 2 of whom died from acute respiratory distress syndrome. Radiotherapy was deferred or interrupted for 40 patients awaiting testing. As the median turnaround time for RT-PCR testing decreased from 1.5 (IQR: 1-4) to </=1-day (P<0.001), the median treatment delay also decreased from 3.5 (IQR: 1.75-5) to 1 business day (IQR: 1-2) [P<0.001]. Each patient was an exposure risk to a median of 5 employees (IQR: 3-6.5) through prolonged close contact. During this timeframe, 39 care-team members were quarantined for a median of 3 days (IQR: 2-11), with a peak of 17 employees simultaneously quarantined. Following implementation of a \"dual PPE policy,\" newly quarantined employees decreased from 2.9 to 0.5 per day. CONCLUSION: The severe adverse events noted among these confirmed-positive cases support the notion that cancer patients are vulnerable to COVID-19. Active tracking, rapid diagnosis, and aggressive source control can mitigate the adverse effects on treatment delays, workforce incapacitation, and ideally outcomes.","Radiother Oncol","Ning, Matthew S","Frances McAleer, Mary","Jeter, Melenda D","Minsky, Bruce D","Ghafar, Robert A","Robinson, Ivy J","Nitsch, Paige L","Zaebst, Denise J","Todd, Sarah E","Nguyen, Jennifer","Lin, Steven H","Liao, Zhongxing","Lee, Percy","Brandon Gunn, G","Klopp, Ann H","Dabaja, Bouthaina S","Nguyen, Quynh-Nhu","Chronowski, Gregory M","Bloom, Elizabeth S","Koong, Albert C","Das, Prajnan","32474129"],"abstract":["BACKGROUND AND PURPOSE: The COVID-19 pandemic warrants operational initiatives to minimize transmission, particularly among cancer patients who are thought to be at high-risk. Within our department, a multidisciplinary tracer team prospectively monitored all patients under investigation, tracking their test status, treatment delays, clinical outcomes, employee exposures and quarantines. MATERIALS AND METHODS: Prospective cohort tested for SARS-COV-2 infection over 35 consecutive days of the early pandemic (03/19/2020-04/22/2020). RESULTS: A total of 121 Radiation Oncology patients underwent RT-PCR testing during this timeframe. Of the 7 (6%) confirmed-positive cases, 6 patients were admitted (including 4 warranting intensive care), 2 of whom died from acute respiratory distress syndrome. Radiotherapy was deferred or interrupted for 40 patients awaiting testing. As the median turnaround time for RT-PCR testing decreased from 1.5 (IQR: 1-4) to </=1-day (P<0.001), the median treatment delay also decreased from 3.5 (IQR: 1.75-5) to 1 business day (IQR: 1-2) [P<0.001]. Each patient was an exposure risk to a median of 5 employees (IQR: 3-6.5) through prolonged close contact. During this timeframe, 39 care-team members were quarantined for a median of 3 days (IQR: 2-11), with a peak of 17 employees simultaneously quarantined. Following implementation of a \"dual PPE policy,\" newly quarantined employees decreased from 2.9 to 0.5 per day. CONCLUSION: The severe adverse events noted among these confirmed-positive cases support the notion that cancer patients are vulnerable to COVID-19. Active tracking, rapid diagnosis, and aggressive source control can mitigate the adverse effects on treatment delays, workforce incapacitation, and ideally outcomes."],"journal":"Radiother Oncol","authors":["Ning, Matthew S","Frances McAleer, Mary","Jeter, Melenda D","Minsky, Bruce D","Ghafar, Robert A","Robinson, Ivy J","Nitsch, Paige L","Zaebst, Denise J","Todd, Sarah E","Nguyen, Jennifer","Lin, Steven H","Liao, Zhongxing","Lee, Percy","Brandon Gunn, G","Klopp, Ann H","Dabaja, Bouthaina S","Nguyen, Quynh-Nhu","Chronowski, Gregory M","Bloom, Elizabeth S","Koong, Albert C","Das, Prajnan"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32474129","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.radonc.2020.05.037","keywords":["covid-19","sars-cov-2","acute respiratory distress syndrome","isolation precautions","nasopharyngeal swab","pandemic","prospective cohort","quarantine","radiation therapy"],"topics":["Prevention"],"weight":1,"_version_":1668341932658524160,"score":192.21269},{"pmid":32464670,"title":"[Implementation of an operational concept in an ENT clinic in the context of the SARS-CoV-2 pandemic].","text":["[Implementation of an operational concept in an ENT clinic in the context of the SARS-CoV-2 pandemic].","The SARS-CoV-2 pandemic poses major challenges for the entire medical care system. Especially in university institutions as maximum care providers, a higher exposure to potentially infectious patients or actual COVID19 patients is to be expected. In a short period of time, an operational concept had to be developed regarding the current hygiene recommendations of the Robert Koch Institute (RKI), the leading medical societies and the internal hospital hygiene plan. Here, patient safety and employee protection are equally important.In cooperation with the Institute for Medical Microbiology and Hospital Hygiene and the occupational medical service, interventions were defined to develop solutions to minimize the COVID-19 transmission risk for examiners and patients despite limited diagnostic and equipment resources. For this purpose, an operational concept was developed, consisting of various individual actions, e. g. the reduction of outpatient treatment to emergencies, life-threatening diseases and urgent aftercare, a double triage of patients and the introduction of treatment teams.The newly developed operational concept was successfully implemented within a few days. After the initial rollout and several \"hygiene inspections\" only minor improvements to the concept were necessary. All measures were documented in the internal quality handbook and are accessible to all employees. Since the SARS-CoV-2 pandemic is a dynamic process with regular changes in the development and information status, the operational concept is regularly reviewed for validity and adjusted as necessary.","Laryngorhinootologie","Weiss, Roxanne","Loth, Andreas","Guderian, Daniela","Diensthuber, Marc","Kempf, Volkhard","Hack, Daniel","Wicker, Sabine","Ciesek, Sandra","Graf, Jurgen","Stover, Timo","Leinung, Martin","32464670"],"abstract":["The SARS-CoV-2 pandemic poses major challenges for the entire medical care system. Especially in university institutions as maximum care providers, a higher exposure to potentially infectious patients or actual COVID19 patients is to be expected. In a short period of time, an operational concept had to be developed regarding the current hygiene recommendations of the Robert Koch Institute (RKI), the leading medical societies and the internal hospital hygiene plan. Here, patient safety and employee protection are equally important.In cooperation with the Institute for Medical Microbiology and Hospital Hygiene and the occupational medical service, interventions were defined to develop solutions to minimize the COVID-19 transmission risk for examiners and patients despite limited diagnostic and equipment resources. For this purpose, an operational concept was developed, consisting of various individual actions, e. g. the reduction of outpatient treatment to emergencies, life-threatening diseases and urgent aftercare, a double triage of patients and the introduction of treatment teams.The newly developed operational concept was successfully implemented within a few days. After the initial rollout and several \"hygiene inspections\" only minor improvements to the concept were necessary. All measures were documented in the internal quality handbook and are accessible to all employees. Since the SARS-CoV-2 pandemic is a dynamic process with regular changes in the development and information status, the operational concept is regularly reviewed for validity and adjusted as necessary."],"journal":"Laryngorhinootologie","authors":["Weiss, Roxanne","Loth, Andreas","Guderian, Daniela","Diensthuber, Marc","Kempf, Volkhard","Hack, Daniel","Wicker, Sabine","Ciesek, Sandra","Graf, Jurgen","Stover, Timo","Leinung, Martin"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32464670","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1055/a-1174-0234","topics":["Prevention"],"weight":1,"_version_":1668079521280032768,"score":174.52327},{"pmid":32251649,"pmcid":"PMC7194667","title":"COVID-19 Pandemic: Staged Management of Surgical Services for Gynecology and Obstetrics.","text":["COVID-19 Pandemic: Staged Management of Surgical Services for Gynecology and Obstetrics.","The COVID-19 pandemic has required an unprecedented global healthcare response requiring maintenance of existing hospital-based services while simultaneously preparing for high-acuity care for infected and sick individuals. Hospitals must protect patients and the diverse healthcare workforce by conserving personal protective equipment and redeployment of facility resources. While each hospital or health system must evaluate their own capabilities and surge capacity, we present principles of management of surgical services during a health emergency and provide specific guidance to help with decision-making. We review the limited evidence from past hospital and community responses to various health emergencies and focus on systematic methods for adjusting surgical services to create capacity, addressing the specific risks of COVID-19. Successful strategies for tiered reduction of surgical cases involve multi-disciplinary engagement of the entire healthcare system and use of a structured risk-assessment categorization scheme which can be applied across the institution. Our institution developed and operationalized this approach over three working days, indicating that immediate implementation is feasible in response to an unforeseen healthcare emergency.","Am J Obstet Gynecol","Weber Lebrun, Emily E","Moawad, Nash S","Rosenberg, Eric I","Morey, Timothy E","Davies, Laurie","Collins, William O","Smulian, John C","32251649"],"abstract":["The COVID-19 pandemic has required an unprecedented global healthcare response requiring maintenance of existing hospital-based services while simultaneously preparing for high-acuity care for infected and sick individuals. Hospitals must protect patients and the diverse healthcare workforce by conserving personal protective equipment and redeployment of facility resources. While each hospital or health system must evaluate their own capabilities and surge capacity, we present principles of management of surgical services during a health emergency and provide specific guidance to help with decision-making. We review the limited evidence from past hospital and community responses to various health emergencies and focus on systematic methods for adjusting surgical services to create capacity, addressing the specific risks of COVID-19. Successful strategies for tiered reduction of surgical cases involve multi-disciplinary engagement of the entire healthcare system and use of a structured risk-assessment categorization scheme which can be applied across the institution. Our institution developed and operationalized this approach over three working days, indicating that immediate implementation is feasible in response to an unforeseen healthcare emergency."],"journal":"Am J Obstet Gynecol","authors":["Weber Lebrun, Emily E","Moawad, Nash S","Rosenberg, Eric I","Morey, Timothy E","Davies, Laurie","Collins, William O","Smulian, John C"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32251649","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.ajog.2020.03.038","keywords":["covid-19","sars cov2","case cancellations","coronavirus","emergency response","gynecology","obstetrics","staged management","surgery","surgical subspecialties"],"topics":["Prevention"],"weight":1,"_version_":1666138491024572416,"score":170.26959},{"pmid":32415869,"title":"Surge after the surge: Anticipating the increased volume and needs of patients with head and neck cancer after the peak in COVID-19.","text":["Surge after the surge: Anticipating the increased volume and needs of patients with head and neck cancer after the peak in COVID-19.","The novel coronavirus disease 2019 (COVID-19) pandemic continues to have extensive effects on public health as it spreads rapidly across the globe. Patients with head and neck cancer are a particularly susceptible population to these effects, and we expect there to be a potential surge in patients presenting with head and neck cancers after the surge in COVID-19. Furthermore, the impact of social distancing measures could result in a shift toward more advanced disease at presentation. With appropriate anticipation, multidisciplinary head and cancer teams could potentially minimize the impact of this surge and plan for strategies to provide optimal care for patients with head and neck cancer.","Head Neck","Bowman, Ryan","Crosby, Dana L","Sharma, Arun","32415869"],"abstract":["The novel coronavirus disease 2019 (COVID-19) pandemic continues to have extensive effects on public health as it spreads rapidly across the globe. Patients with head and neck cancer are a particularly susceptible population to these effects, and we expect there to be a potential surge in patients presenting with head and neck cancers after the surge in COVID-19. Furthermore, the impact of social distancing measures could result in a shift toward more advanced disease at presentation. With appropriate anticipation, multidisciplinary head and cancer teams could potentially minimize the impact of this surge and plan for strategies to provide optimal care for patients with head and neck cancer."],"journal":"Head Neck","authors":["Bowman, Ryan","Crosby, Dana L","Sharma, Arun"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32415869","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1002/hed.26260","keywords":["covid-19","sars-cov-2","head and neck cancer","novel coronavirus"],"locations":["optimal"],"topics":["Prevention"],"weight":1,"_version_":1666994545872601089,"score":170.22035},{"pmid":32342541,"title":"Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic.","text":["Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic.","BACKGROUND: COVID-19 pandemic has strained human and material resources around the world. Practices in surgical oncology had to change in response to these resource limitations, triaging based on acuity, expected oncologic outcomes, availability of supportive resources, and safety of healthcare personnel. METHODS: The MD Anderson Head and Neck Surgery Treatment Guidelines Consortium devised the following to provide guidance on triaging Head and Neck cancer (HNC) surgeries based on multidisciplinary consensus. HNC subsites considered included aerodigestive tract mucosa, sinonasal, salivary, endocrine, cutaneous, and ocular. RECOMMENDATIONS: Each subsite is presented separately with disease-specific recommendations. Options for alternative treatment modalities are provided if surgical treatment needs to be deferred. CONCLUSION: These guidelines are intended to help clinicians caring for HNC patients appropriately allocate resources during a healthcare crisis, such as the COVID-19 pandemic. We continue to advocate for individual consideration of cases in a multidisciplinary fashion based on individual patient circumstances and resource availability.","Head Neck","Head, Anderson","Maniakas, Anastasios","Jozaghi, Yelda","Zafereo, Mark E","Sturgis, Erich M","Su, Shirley Y","Gillenwater, Ann M","Gidley, Paul W","Lewis, Carol M","Diaz, Eduardo Jr","Goepfert, Ryan P","Kupferman, Michael E","Gross, Neil D","Hessel, Amy C","Pytynia, Kristen B","Nader, Marc-Elie","Wang, Jennifer R","Lango, Miriam N","Kiong, Kimberley L","Guo, Theresa","Zhao, Xiao","Yao, Christopher M K L","Appelbaum, Eric","Alpard, Jennifer","Garcia, Jose A","Terry, Shawn","Flynn, Jill E","Bauer, Sarah","Fournier, Danielle","Burgess, Courtlyn G","Wideman, Cayla","Johnston, Matthew","You, Chenxi","De Luna, Rolando","Joseph, Liza","Diersing, Julia","Prescott, Kaitlin","Heiberger, Katherine","Mugartegui, Lilian","Rodriguez, Jessica","Zendehdel, Sara","Sellers, Justin","Friddell, Rebekah A","Thomas, Ajay","Khanjae, Sonam J","Schwarzlose, Katherine B","Chambers, Mark S","Hofstede, Theresa M","Cardoso, Richard C","Aponte Wesson, Ruth","Won, Alex","Otun, Adegbenga O","Gombos, Dan S","Al-Zubidi, Nagham","Hutcheson, Katherine A","Gunn, G Brandon","Rosenthal, David I","Gillison, Maura L","Ferrarotto, Renata","Weber, Randal S","Hanna, Ehab Y","Myers, Jeffrey N","Lai, Stephen Y","32342541"],"abstract":["BACKGROUND: COVID-19 pandemic has strained human and material resources around the world. Practices in surgical oncology had to change in response to these resource limitations, triaging based on acuity, expected oncologic outcomes, availability of supportive resources, and safety of healthcare personnel. METHODS: The MD Anderson Head and Neck Surgery Treatment Guidelines Consortium devised the following to provide guidance on triaging Head and Neck cancer (HNC) surgeries based on multidisciplinary consensus. HNC subsites considered included aerodigestive tract mucosa, sinonasal, salivary, endocrine, cutaneous, and ocular. RECOMMENDATIONS: Each subsite is presented separately with disease-specific recommendations. Options for alternative treatment modalities are provided if surgical treatment needs to be deferred. CONCLUSION: These guidelines are intended to help clinicians caring for HNC patients appropriately allocate resources during a healthcare crisis, such as the COVID-19 pandemic. We continue to advocate for individual consideration of cases in a multidisciplinary fashion based on individual patient circumstances and resource availability."],"journal":"Head Neck","authors":["Head, Anderson","Maniakas, Anastasios","Jozaghi, Yelda","Zafereo, Mark E","Sturgis, Erich M","Su, Shirley Y","Gillenwater, Ann M","Gidley, Paul W","Lewis, Carol M","Diaz, Eduardo Jr","Goepfert, Ryan P","Kupferman, Michael E","Gross, Neil D","Hessel, Amy C","Pytynia, Kristen B","Nader, Marc-Elie","Wang, Jennifer R","Lango, Miriam N","Kiong, Kimberley L","Guo, Theresa","Zhao, Xiao","Yao, Christopher M K L","Appelbaum, Eric","Alpard, Jennifer","Garcia, Jose A","Terry, Shawn","Flynn, Jill E","Bauer, Sarah","Fournier, Danielle","Burgess, Courtlyn G","Wideman, Cayla","Johnston, Matthew","You, Chenxi","De Luna, Rolando","Joseph, Liza","Diersing, Julia","Prescott, Kaitlin","Heiberger, Katherine","Mugartegui, Lilian","Rodriguez, Jessica","Zendehdel, Sara","Sellers, Justin","Friddell, Rebekah A","Thomas, Ajay","Khanjae, Sonam J","Schwarzlose, Katherine B","Chambers, Mark S","Hofstede, Theresa M","Cardoso, Richard C","Aponte Wesson, Ruth","Won, Alex","Otun, Adegbenga O","Gombos, Dan S","Al-Zubidi, Nagham","Hutcheson, Katherine A","Gunn, G Brandon","Rosenthal, David I","Gillison, Maura L","Ferrarotto, Renata","Weber, Randal S","Hanna, Ehab Y","Myers, Jeffrey N","Lai, Stephen Y"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32342541","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/hed.26206","keywords":["sars-cov2","oncology","otolaryngology"],"topics":["Prevention"],"weight":1,"_version_":1666138495125553152,"score":163.78595}]}